José Ponce
Impact in
- Oncology top 5%
- PARP inhibition in cancer therapy
- HER2/EGFR in Cancer Research
- Colorectal Cancer Surgical Treatments
- Gastroenterology top 5%
- Gastroesophageal reflux and treatments
Papers in
- Co-authors
- Hope S. Rugo (1 shared paper)David Maag (1 shared paper)Mehra Golshan (1 shared paper)Sibylle Loibl (1 shared paper)William M. Sikov (1 shared paper)Joyce O’Shaughnessy (1 shared paper)Kristi McIntyre (1 shared paper)Priya Rastogi (1 shared paper)
In The Last Decade
José Ponce
24 papers receiving 963 citations
José Ponce's Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 541
- Gastroenterology 96
- Cancer Research 254
- Pulmonary and Respiratory Medicine 120
- Genetics 89
Countries citing papers authored by José Ponce
This map shows the geographic impact of José Ponce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Ponce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Ponce more than expected).
Fields of papers citing papers by José Ponce
This network shows the impact of papers produced by José Ponce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Ponce. The network helps show where José Ponce may publish in the future.
Co-authors
The 25 scholars most cited alongside José Ponce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial Hit paper breakdown → | 2018 | 537 |
| 2 | 2011 | 110 | |
| 3 | Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group. | 1998 | 96 |
| 4 | 2014 | 74 | |
| 5 | 2017 | 42 | |
| 6 | 2013 | 28 | |
| 7 | 2007 | 19 | |
| 8 | 2013 | 17 | |
| 9 | 2006 | 14 | |
| 10 | 2021 | 12 | |
| 11 | 2006 | 11 | |
| 12 | 2024 | 5 | |
| 13 | 2001 | 4 | |
| 14 | Response to short-course chemotherapy of patients with initial resistance to antituberculosis drugs. | 1988 | 3 |
| 15 | [The clinical significance of the magnitude of esophageal dilatation in idiopathic achalasia]. | 1996 | 3 |
| 16 | 2016 | 2 | |
| 17 | Analysis of the predictive value of clinical data in patients with suspected colonic disease. | 1997 | 2 |
| 18 | 2007 | 2 | |
| 19 | La respuesta emocional y posibles correlatos con parámetros biológicos. | 1999 | 1 |
| 20 | 2025 | 1 |
About José Ponce
José Ponce is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Molecular Biology and Gastroenterology, having authored 26 papers that have together received 987 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Genomics and Diagnostics (2 papers), Gastroesophageal reflux and treatments (2 papers), Lung Cancer Research Studies (2 papers), Urologic and reproductive health conditions (1 paper), FOXO transcription factor regulation (1 paper) and Management of metastatic bone disease (1 paper). The work is most often cited by research in Oncology (541 citations), Gastroenterology (96 citations), Cancer Research (254 citations), Pulmonary and Respiratory Medicine (120 citations) and Genetics (89 citations). José Ponce has collaborated with scholars based in Spain, Germany and France. Frequent co-authors include Hope S. Rugo, David Maag, Mehra Golshan, Sibylle Loibl, William M. Sikov, Joyce O’Shaughnessy, Kristi McIntyre, Priya Rastogi, Gϋnter von Minckwitz and Norman Wolmark. Their work appears in journals such as Clinical & Translational Oncology, Journal of Clinical Oncology, Human Pathology, ESMO Open and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.